Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Assets Average (2016 - 2025)

United Therapeutics' Assets Average history spans 16 years, with the latest figure at $7.6 billion for Q4 2025.

  • For Q4 2025, Assets Average rose 5.14% year-over-year to $7.6 billion; the TTM value through Dec 2025 reached $7.6 billion, up 5.14%, while the annual FY2025 figure was $7.6 billion, 4.91% up from the prior year.
  • Assets Average for Q4 2025 was $7.6 billion at United Therapeutics, roughly flat from $7.6 billion in the prior quarter.
  • Across five years, Assets Average topped out at $7.8 billion in Q2 2025 and bottomed at $4.6 billion in Q1 2021.
  • The 5-year median for Assets Average is $6.6 billion (2023), against an average of $6.3 billion.
  • The largest annual shift saw Assets Average rose 21.02% in 2023 before it increased 1.03% in 2024.
  • A 5-year view of Assets Average shows it stood at $5.1 billion in 2021, then rose by 15.74% to $5.9 billion in 2022, then rose by 19.99% to $7.1 billion in 2023, then increased by 2.09% to $7.2 billion in 2024, then increased by 5.14% to $7.6 billion in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Assets Average are $7.6 billion (Q4 2025), $7.6 billion (Q3 2025), and $7.8 billion (Q2 2025).